mRNA based therapy (ModeRNA)

N/A

Report date: 2025/03/20 15:51:56
NME

Base Information

Drug NamemRNA based therapy (ModeRNA)
Drug Alias Nameornithine transcarbamylase deficiency gene therapy (ModeRNA)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsOrnithine Carbamoyltransferase Deficiency Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesModerna Inc
China Registration ClassN/A

Develop Information

Active CompaniesModerna Inc
Inactive CompaniesN/A
Active IndicationsOrnithine Carbamoyltransferase Deficiency Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A